The critics of Bionano (NASDAQ:BNGO) stock are ignoring and/or severely underestimating developments involving its DNA mapping tool, Saphyr. Source: Natali_ Mis/ShutterStock.com Specifically, there is ...
Image source: The Motley Fool. Management signaled a business model shift prioritizing increased consumable and software usage among routine users rather than aggressive expansion of the installed ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results